Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-24

FDA Approved: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

The FDA approved Ajanta Pharma USA Inc.'s supplemental application for a combination tablet of amlodipine besylate and olmesartan medoxomil under ANDA207216, en…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate and Olmesartan Medoxomil (amlodipine besylate and olmesartan medoxomil)

Snippet

SUPPL AP for AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL (AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL)